Cargando…
COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination
Ivan Gentile and Nicola Schiano Moriello discuss the potential of monoclonal antibody prophylaxis against COVID-19 infection in immunocompromised patients.
Autores principales: | Gentile, Ivan, Schiano Moriello, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836303/ https://www.ncbi.nlm.nih.gov/pubmed/35089920 http://dx.doi.org/10.1371/journal.pmed.1003917 |
Ejemplares similares
-
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients
por: Biagio, Pinchera, et al.
Publicado: (2022) -
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19
por: Pinchera, Biagio, et al.
Publicado: (2023) -
The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel
por: Gentile, Ivan, et al.
Publicado: (2023) -
Update on the Management of Surgical Site Infections
por: Pinchera, Biagio, et al.
Publicado: (2022) -
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study
por: Gentile, Ivan, et al.
Publicado: (2022)